Number of men living with prostate cancer in the UK has surged by 100,000 since 2020 - with one diagnosed every eight minutes

The number of men living with prostate cancer in the UK has increased by 100,000 since 2020, bringing the total to approximately 600,000 individuals, according to data released by Macmillan Cancer Support. The charity reports that over 68,000 new cases are diagnosed annually, equating to one diagnosis every eight minutes. This rise underscores a growing public health concern, particularly as prostate cancer remains the most common cancer among British men. The surge in diagnoses follows a steady trend over several years, with the figure of 600,000 men living with the condition representing a notable jump from around 500,000 six years prior. Macmillan Cancer Support highlighted that early-stage prostate cancer often shows no symptoms, making regular check-ups and open communication with healthcare professionals crucial. Dr. Anthony Cunliffe, lead medical adviser at the charity, emphasized that many men mistakenly believe feeling well guarantees they do not have the disease, a misconception that could delay critical treatment. Symptoms of advanced prostate cancer typically include difficulties with urination, frequent nighttime trips to the bathroom, a sensation of incomplete bladder emptying, urgent need to urinate, and presence of blood in urine or semen. These signs often appear when the cancer has progressed sufficiently to affect the urinary tract. Despite the lack of early warning signs, experts stress that proactive engagement with general practitioners is essential for timely detection and management. Prostate cancer predominantly affects men over 50, though it can manifest earlier in specific populations such as Black men and those with a familial history of the disease. Dr. Cunliffe noted that while some doctors may opt for a physical examination of the prostate, this is not always required. A blood test known as the PSA (prostate-specific antigen) test is commonly used to assess risk levels. However, recent guidelines issued by the UK National Screening Committee advised against universal PSA screening, citing potential risks outweighing benefits. The decision sparked criticism from former Prime Minister Lord Cameron, who argued it represented a regression in efforts to combat the disease. Despite the caution regarding widespread screening, the committee acknowledged the value of targeted approaches. It suggested that a small group of high-risk men, those with specific genetic mutations, should undergo screening. Additionally, officials announced plans to expand a screening trial to include all eligible Black men, recognizing disparities in access to care and outcomes within this demographic. Campaigns led by media outlets like the Daily Mail aim to advocate for broader screening initiatives, emphasizing the importance of identifying and treating prostate cancer at its earliest stages. Prominent figures such as Sir Chris Hoy and Sir Stephen Fry, both survivors of the disease, support these efforts, underscoring the personal stakes involved in addressing the issue effectively. As the debate continues over optimal strategies for early detection, the focus remains on ensuring that men receive accurate information and appropriate care to improve survival rates and quality of life.